VeriMompolyacrylate-35 est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety decision identifying reproductive hazard for the high‑molecular‑weight acrylate polymer. Polymers such as polyacrylates are generally regarded as non‑systemic and inert in cosmetic use; residual monomers (if present) are the main toxicological concern. Sources: ECHA Annex VI (no harmonised H360/H361 for polyacrylate polymers), CosIng/PubChem entries for polyacrylate polymers, CIR precedent that polymeric acrylates are safe as used when residual monomers are controlled.
Related ingredients
Frequently asked questions
- polyacrylate-35 est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety decision identifying reproductive hazard for the high‑molecular‑weight acrylate polymer. Polymers such as polyacrylates are generally regarded as non‑systemic and inert in cosmetic use; residual monomers (if present) are the main toxicological concern. Sources: ECHA Annex VI (no harmonised H360/H361 for polyacrylate polymers), CosIng/PubChem entries for polyacrylate polymers, CIR precedent that polymeric acrylates are safe as used when residual monomers are controlled.
- polyacrylate-35 est-il sûr pendant l'allaitement ?
- No evidence of maternal systemic reproductive or lactation toxicity for the polymer; negligible dermal absorption for high‑MW acrylate polymers implies minimal transfer into breastmilk. Main risk would be from low‑molecular‑weight residual monomers, but those would be controlled by impurity specifications. Sources: PubChem/CosIng polymer data and regulatory assessments indicating low absorption of high‑MW acrylates.
- polyacrylate-35 est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no infant‑specific reproductive or developmental hazard data for the polymer itself. Exposure: increase applied by one step because infant skin has higher permeability and surface‑area‑to‑weight; although the polymer is poorly absorbed in adults, some low-level dermal uptake or greater surface exposure in infants makes exposure category 'low but measurable'. Concern remains primarily about residual monomers rather than the polymer itself. Sources: general polymer toxicology guidance (CosIng/PubChem) and regulatory practice considering polymers low‑absorption but infant skin differences.
- Comment VeriMom évalue-t-il polyacrylate-35 ?
- VeriMom évalue polyacrylate-35 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à polyacrylate-35 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à polyacrylate-35 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.